No Data
No Data
Express News | Myriad Genetics Inc: Collaborates With GSK to Improve Access to Hrd Testing in 9 Countries
Express News | Myriad Genetics Collaborates With GSK To Improve Access On Homologous Recombination Deficiency Testing In 9 Countries
Myriad Genetics Collaborates With GSK to Improve Access to HRD Testing in 9 Countries
SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at improving access to
Myriad Genetics Insiders Sell US$5.9m Of Stock, Possibly Signalling Caution
The fact that multiple Myriad Genetics, Inc. (NASDAQ:MYGN) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When evaluating in
Insider Sale: Director Daniel Spiegelman Sells Shares of Myriad Genetics Inc (MYGN)
Myriad Genetics(MYGN.US) Director Sells US$167.01K in Common Stock
$Myriad Genetics(MYGN.US)$ Director SPIEGELMAN DANIEL K sold 7,576 shares of common stock on Jun 3, 4, 2024 at an average price of $22.04 for a total value of $167.01K.Source: Announcement What is sta
Jaguar8 : Yes it’s quite disappointing that people don’t realize the importance of this.
TrytosaveabitOP Jaguar8: Yup! I have a volume and price move alerts set! Hehehe
Jaguar8 TrytosaveabitOP: What volume do you usually set like 1M?
TrytosaveabitOP Jaguar8: 300K in 3 minutes
Jaguar8 TrytosaveabitOP: Wow that is fast volume
View more comments...